NeuroBo Pharmaceuticals has a beta of -0.28, indicating that its share price is 128% less volatile than the S&P 500. Comparatively, Galmed Pharmaceuticals has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500.